drugset / Trial / NCT01788774
Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths
RandomizedParallel-groupOpen-labelTreatment
Summary
This clinical trial is designed to evaluate different dosages of risperidone ISM, a new long-acting injectable form.
Timeline
- Start
- 2013-04
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risperidone | Other / unclassified | 50 mg | Intramuscular |
| Subject | Risperidone | Other / unclassified | 75 mg | Intramuscular |
| Subject | Risperidone | Other / unclassified | 100 mg | Intramuscular |